Amarin Corp Plc (AMRN)

[HinduKush]

The latest from the troops on the frontline that I can glean is that all CVS stores are mandating the switch based on generic Tier predominance and telling the patients that the HIKMA generic will follow-- it has taken up to 3 weeks apparently anecdotally... Further, Availability here in California is improving but varies with Rite-Aid stores having the generic more readily than the CVS's. The pharmacists we sample are following DAW but largely ignoring the diagnosis codes/ written indications "for R-IT CV reduction etc.." but there are instances where the Vascepa is being switched even to generic ethyl esters (mixed) or Lovaza generic. Expect a ~10,000 drop (I have extrapolated based on prior correlations between my regions script behaviour and national figures)-in new /refill scripts over next month at least as this kicks in. Ironically, the price difference for this generic is not that amazing so this is not a big savings push by the customer here... Surely the time for Amrn to seal a thanksgiving deal with large pharmacy benefit managers and large Medicare part D contractors and state medical organizations and keep it in place for 1 year while playing the API supply games...
HK